Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Highly Accessed Research article

T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study

Ada Tosovic1*, Anne-Greth Bondeson1, Lennart Bondeson2, Ulla-Britt Ericsson3 and Jonas Manjer14

Author Affiliations

1 Department of Surgery, Skåne University Hospital Malmö, Lund University, Malmö, Sweden

2 Department of Pathology, University and Regional Laboratories Region Skåne, Lund University, Malmö, Sweden

3 Department of Endocrinology, Skåne University Hospital Malmö, Lund University, Malmö, Sweden

4 Department of Reconstructive Surgery, Skåne University Hospital Malmö, Lund University, Malmö, Sweden

For all author emails, please log on.

BMC Cancer 2014, 14:536  doi:10.1186/1471-2407-14-536

Published: 24 July 2014

Abstract

Background

The issue of a potential association between thyroid conditions/hormones and breast cancer has been studied extensively during the last decades but the results have been inconclusive and almost no studies have investigated breast cancer aggressiveness. We have previously found a positive association between prospectively measured levels of triiodothyronine (T3) and breast cancer incidence as well as breast cancer mortality. We now investigated prediagnostic T3 levels in relation to specific prognostic factors in breast cancer.

Methods

The Malmö Preventive Project is a population-based prospective cohort including 2185 women in whom T3 levels were measured at baseline. That is, total T3 levels were measured before a potential diagnosis of breast cancer. Mean follow-up was 23.3 years and 149 women in the study population were diagnosed with invasive breast cancer. Tumours were classified according to selected prognostic factors of breast cancer; i.e. grade, tumour size, lymph node metastasis, and hormonal receptor status. T3 was handled both as tertiles and as a continuous variable. A Cox’s proportional hazards analysis yielded hazard ratios with 95% confidence intervals. All analyses were also restricted to postmenopausal women.

Results

Overall there was a statistically significant association between T3 and “all” breast cancers. The adjusted Hazard Ratio (HR) in the third tertile, as compared to the first, was (1.61:1.07-2.43). There was a statistically significant positive association between the third T3 tertile and large tumours, i.e. > 20 mm, (3.17:1.20-8.36) and the occurrence of lymph node metastases, (4.53:1.60-12.83). Other prognostic factors positively associated with T3 were negative oestrogen receptor (ER) status, (3.52:1.32-9.41) and negative progesterone receptor (PGR) status, (3.52:1.42-8.75). The analyses of T3 as a continuous variable and analysis restricted to postmenopausal women, confirmed the results but also showed an association with smaller tumours and in postmenopausal women a contemporary association with negative lymph nodes.

Conclusions

This prospective study of serum T3 levels in relation to breast cancer aggressiveness is the first of its kind. We found statistically significant positive associations between higher prediagnostic T3 levels and larger tumours, occurrence of lymph node metastases, and negative ER and PGR status.

Keywords:
Breast cancer; Triiodothyronine; Prognostic factors